HIV Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, a therapeutic vaccine would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV.

Historically, vaccines have been our best weapon against the world’s deadliest infectious diseases, including smallpox, polio, measles, and yellow fever. Unfortunately, we currently do not have a vaccine for HIV. The virus has unique ways of evading the immune system, and the human body seems incapable of mounting an effective immune response against it. As a result, scientists do not have a clear picture of what is needed to provide protection against HIV.

  • B cell-based vaccines
  • Challenges Facing AIDS Vaccine Development
  • Emerging Clinical Trials
  • HIV Vaccine Strategies
  • Innate & Mucosal Immunity
  • Innovations in HIV Vaccine Discovery
  • Preventive HIV Vaccines
  • T cell-based vaccines
  • Viral Vaccine Vectors

Related Conference of HIV Vaccines

September 21-22, 2026

44th Euro Global Summit and Expo on Vaccines & Vaccination

Barcelona, Spain
September 28-29, 2026

8th World Congress on Vaccine and Immunology

Toronto, Canada
November 16-17, 2026

7th International Conference on Vaccine Research

Tokyo, Japan

HIV Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in